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Introduction: Administration of bone marrow-derived mesenchymal stem cells (MSCs) after myocardial infarction
(MI) results in modest functional improvements. However; the effect of microenvironment changes after MI, such as
elevated levels of oxidative stress on cardiogenic gene expression of MSCs, remains unclear.
Methods: MSCs were isolated from the bone marrow of adult rats and treated for 1 week with H2O2 (0.1 to 100
μM) or 48 hours with glucose oxidase (GOX; 0 to 5 mU/ml) to mimic long-term pulsed or short-term continuous
levels of H2O2, respectively.
Results: In 100 μM H2O2 or 5 mU/ml GOX-treated MSCs, mRNA expression of selected endothelial genes (Flt1, vWF,
PECAM1), and early cardiac marker (nkx2-5, αMHC) increased significantly, whereas early smooth muscle markers
(smooth muscle α-actin and sm22α) and fibroblast marker vimentin decreased, as measured with real-time PCR.
Interestingly, mRNA expression and activity of the cell-surface receptor Notch1 were significantly increased, as were
its downstream targets, Hes5 and Hey1. Co-treatment of MSCs with 100 μM H2O2 and a γ-secretase inhibitor that
prevents Notch signaling abrogated the increase in cardiac and endothelial genes, while augmenting the decrease
in smooth muscle markers. Further, on GOX treatment, a significant increase in Wnt11, a downstream target of
Notch1, was observed. Similar results were obtained with adult rat cardiac-derived progenitor cells.
Conclusions: These data suggest that H2O2- or GOX-mediated oxidative stress upregulates Notch1 signaling, which
promotes cardiogenic gene expression in adult stem/progenitor cells, possibly involving Wnt11. Modulating the
balance between Notch activation and H2O2-mediated oxidative stress may lead to improved adult stem cell-based
therapies for cardiac repair and regeneration.
Keywords: Cardiac progenitor cells, Gene expression, Glucose oxidase, Hydrogen peroxide, Mesenchymal stem
cells, Notch1Introduction
Cardiovascular disease is the leading cause of global mor-
bidity and mortality [1]. Among cardiovascular diseases,
myocardial infarction (MI) leads to irreversible damage to
the myocardium and progressive loss of function, eventu-
ally leading to heart failure. Although many therapies
attempt to improve functionality of the heart, the only* Correspondence: michael.davis@bme.emory.edu
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reproduction in any medium, provided the orcure for heart failure is cardiac transplantation. Owing to
low availability of donor hearts, newer treatments that
restore tissue and function are greatly needed. Although
studies have shown functional improvement on injection
of various stem cells, the precise molecular mechanism
responsible for the improvement is unclear. Accumulating
lines of evidence indicate beneficial effects of bone-
marrow-derived mesenchymal stem cells (MSCs) for
treating MI in small- and large-animal studies [2]. Whereas
MSCs are capable of differentiating into multiple lineages
[3], on delivery to the heart after acute MI, cardiogenic (all
cell types in the myocardium) differentiation was noted [4].
Additionally, several studies have shown improvementsral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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bone marrow [5] or by augmenting this endogenous
MSC response via injection of Granulocyte-macrophage
colony-stimulating factor (GM-CSF) and other stem
cell-mobilizing factors [6]. Finally, early human clinical
trials demonstrated modest, yet significant, improvements
in cardiac performance after MSC administration [7,8].
Extensive published studies demonstrate significant
increases in reactive oxygen species (ROS) almost imme-
diately after an acute MI. Elevated levels of ROS have
deleterious effects on the cardiovascular system and are
critical in the pathophysiology of heart failure. Potential
sources of ROS in the myocardium include the NADPH
oxidases of fibroblasts and infiltrating inflammatory
cells, as well as the myocytes themselves [9]. Ischemic
injury further elevates ROS production in these cells,
which may influence differentiation of endogenous or
implanted stem cells at the infarct site. Although effects
of ROS on cardiac cell death, remodeling, and function
are well studied, stem and progenitor cells that could be
used for potential regeneration have both adaptive and
maladaptive responses to oxidative stress. For example,
acute bursts of ROS to embryonic stem cells (ESCs) in
culture facilitate differentiation toward the cardiomyocyte
phenotype, whereas prolonged exposure to H2O2 inhibits
differentiation [10]. Although the effect of ROS on certain
stem cell types is fairly established, the exact signaling
pathways regulated by ROS, especially in the cardiogenic
differentiation of stem cells, are under intensive investiga-
tion. Thus, pinpointing the exact signals modulated by
ROS, leading to alterations in MSC differentiation, is of
great therapeutic interest.
One of the major signaling pathways involved in stem
cell differentiation is the Notch signaling pathway. Notch
signaling is an evolutionarily conserved intercellular
communication pathway that regulates diverse cellular
processes, ranging from cell-fate decision, differenti-
ation, and proliferation to apoptosis. Activation of the
Notch receptor by adjacent cell surface-bound ligands of
the Jagged and Delta family leads to proteolytic cleavage
and nuclear translocation of the Notch intracellular do-
main (NICD) and subsequent transcriptional regulation
of target genes, leading to maintenance of cells in an un-
committed state or induction of cell-type-specific differ-
entiation [11]. Notch signaling promotes early cardiac
development [12] and has also been identified to precede
heart regeneration in zebrafish [13]. Further, certain mu-
tations in Notch ligands or receptors are associated with
embryonic lethality in mice [14]. Apart from regulating
normal development and damage-induced repair, Notch
signaling has also been found to promote cardiomyocyte
survival [15]. Notch activation has been shown to pro-
mote cardiac gene expression in circulating endothelial
progenitor cells [16], bone-marrow derived MSCs [17],and cardiac progenitors [18], while attenuating cardiac
differentiation of embryonic stem cells [19].
The effects of Notch signaling on different cell types
are well studied, but its regulation by oxidative stress is
unknown. We therefore sought to determine the role of
oxidative stress on cardiogenic gene expression in MSCs
and whether Notch signaling plays a role in directing
differentiation of MSCs in the setting of elevated local
H2O2 levels after MI. Our data suggest that H2O2 or
glucose oxidase-mediated oxidative stress promotes car-
diogenic differentiation in adult stem/progenitor cells
through upregulation of Notch1 signaling, possibly in-
volving Wnt11.
Materials and methods
Mesenchymal stem cell isolation
Mesenchymal stem cells were obtained from the femur
and tibia of adult male Sprague–Dawley rats with Percoll
density gradient centrifugation and adherence to tissue-
culture flasks. MSCs were used from passages 2 to 4 cul-
tured on Minimal Essential Media alpha (MEMα; Hyclone,
Logan, USA) supplemented with 20% fetal bovine serum
(Hyclone), L-glutamine (Cellgro, Mediatech, USA), and
100 U penicillin-streptomycin (Invitrogen, Carlsbad, USA).
Trilineage differentiation of MSCs
To determine the trilineage differentiation capacity, the
MSCs were cultured in adipogenic (SR811D250; Amsbio,
Abingdon, UK), osteogenic (SR417D250; Amsbio), or
chondrogenic (SC00B5-2; Vitro Biopharma, Golden, USA)
media for 21 days with media replenishment every 3 days.
The MSCs were also cultured for 1 week ± 100 μM H2O2.
To demonstrate adipogenic differentiation, the cells were
stained with 0.3% Oil Red O (O0625; Sigma, St. Louis,
USA) in isopropanol for 30 minutes and rinsed with PBS.
For osteogenic differentiation, the cells were stained with
1% alizarin red (500–4; RiccaChem, Arlington, USA) for 15
minutes. For chondrogenic differentiation, cells were
stained with 0.5% toluidine blue O in PBS (198161-5G;
Sigma). The stained cells were imaged under a phase-
contrast microscope (Olympus, Pittsburgh, USA).
Cardiac progenitor cell isolation
Cardiac progenitor cells (CPCs) were isolated from the
hearts of adult male Sprague–Dawley rats by selection
of cKit+ cells with anti-cKit antibody (H-300; Santa Cruz,
Dallas, USA)-coated magnetic beads (Dynal, Carlsbad,
USA), as previously described [20].
Characterization of MSCs and CPCs
The surface expression of c-kit (H-300; Santa Cruz), CD45
(Invitrogen), CD34 (sc-7324; Santa Cruz), CD73 (551123;
BD Pharmingen, San Jose, USA), CD90 (554898; BD
Pharmingen, San Jose, USA), and CD105 (bs-0579R; Bioss,
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transcription factors nkx2-5 (sc-14033; Santa Cruz), and
gata4 (sc-9053; SantaCruz) in CPCs was determined with
flow analysis by using an FACSCalibur (Becton Dickinson,
New Jersey, USA). The isotypes of each antibody served as
the negative control.
Induction of oxidative stress in MSCs and CPCs
To induce acute oxidative stress, MSCs or CPCs were cul-
tured in serum-free media with Insulin/Transferrin/Selen-
ium (ITS) containing H2O2 (0 to 100 μM; Fisher Scientific,
New Hampshire, USA) for 1 week, or glucose oxidase (0 to
5 mU/ml; Sigma) for 48 hours. Media was replenished
every day with fresh media with or without H2O2. MSC
and CPC growth media contain 5.5 mM and 10 mM glu-
cose, respectively, and the addition of GOX results in con-
tinuous generation of H2O2.
Gene expression
Total RNA was isolated by using the QIA RNeasy
kit (Qiagen, Valencia, USA) as per maunfacturer’s instruc-
tions. First-strand cDNA was synthesized as descri-
bed [21]. Quantitative real-time PCR was performed
on a StepOne Plus real-time PCR system (Applied
Biosystems, Carlsbad, USA) by using specific primers for
the cardiogenic and Notch1-related genes (see Additional
file 1, Table S1). Gene-expression data were normalized to
GAPDH in the H2O2-treated MSCs and to 18S in the
GOX-treated MSCs. GAPDH is a gene involved in glucose
metabolism and, as addition of glucose oxidase (GOX)
alters the glucose levels in the media, 18S and not
GAPDH was used as the housekeeping gene for studies
involving GOX.
Protein expression
MSCs were treated with or without 5 mU/ml GOX
for 48 hours. The protein expression of α-MHC
(ab50967; Abcam, Cambridge, UK), Flt1 (ab32152;
Abcam, Cambridge, UK), and smooth muscle α-actin
(SAB250093; Sigma) was determined with flow analysis by
using an FACSCalibur (Becton Dickinson). Primary anti-
bodies were used at 1:300, and appropriate secondary anti-
bodies were used at 1:500 with isotype controls.
Measurement of Notch intracellular domain
Total protein was isolated as described [21]. Equal
amounts of protein were loaded on 4% to 15% SDS-
PAGE gradient gel (Bio-Rad, Berkeley, USA). After
transfer, the nitrocellulose membrane was probed with
anti-Notch intracellular domain (Cell Signaling, Beverly,
USA) antibody. A horseradish peroxidase-conjugated
goat anti-rabbit secondary antibody was used (Bio-Rad),
and chemiluminescent signals were obtained on a Kodak
Imager Station 4000 MM Pro (Carestream MolecularImaging, Rochester, USA). NICD protein levels were
normalized to GAPDH (Santa Cruz).
Chemical inhibition of Notch signaling
MSCs were treated with a γ-secretase inhibitor IX DAPT
(N-[N-(3,5-difluorophenacetyl-L-alanyl)]-S-phenylglycine
t-butyl ester; Calbiochem, Billerica, USA, 10 μM) every
day for 1 week to inhibit Notch1 activation in MSCs ±
H2O2. On day 7, RNA and protein were harvested for sub-
sequent qRT-PCR and Western blotting, respectively.
siRNA-mediated knockdown of Notch1
To determine the optimal transfection reagent, MSCs
were transfected with 100 nM mock siRNA labeled
with Cy3 for 48 hours by using oligofectamine (Life
Technologies, Carlsbad, USA), HiPerfect (Qiagen), or
Lipofectamine RNAimax (Life Technologies), according
to the manufacturer’s instructions. The transfection effi-
ciency was determined with flow analysis (FACSCalibur;
Becton Dickinson) and fluorescent microscopy (Nikon).
To knockdown Notch1 expression in MSCs, the cells were
transfected with 25 nM either QIAgen Allstar Negative
control siRNA (siNC) or QIA siNotch1 (S101920730)
with oligofectamine (Life Technologies), according to the
manufacturer’s instructions. After 48 hours, RNA and
protein were harvested for subsequent qRT-PCR and
Western blotting, respectively.
Gene-expression analysis with PCR array
Based on the manufacturer’s instructions, the Qiagen Rat
Notch PCR Array PARN-059A was used to analyze gene ex-
pression in MSCs treated with or without 5 mU/ml GOX.
Statistical analysis
All data are expressed as mean ± SEM. To determine sig-
nificance, either an analysis of variance (ANOVA) was done
followed by the appropriate post hoc test, or a Student t test
was performed by using GraphPad Prism5. A P value <0.05
was considered significant.
Results
Characterization of mesenchymal stem cells
Mesenchymal stem cells (MSCs) had a spindle-shaped,
fibroblast-like morphology and expressed common mes-
enchymal cell-surface markers, c-Kit, CD73, CD90, and
CD105, with low expression of the hematopoietic
markers CD45 and CD34 (Figure 1B). To determine the
multipotent trilineage differentiation capacity, the MSCs
were cultured for 21 days in media that promote differ-
entiation into adipogenic, osteogenic, and chondrogenic
lineages. As shown in Figure 1A, the MSCs differenti-
ated into the three lineages, as demonstrated by
staining for oil red O, alizarin red, and toluidine blue, re-
spectively. Moreover, treatment with 100 μM H2O2 for 1
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Figure 1 Characterization of mesenchymal stem cells. (A) The trilineage differentiation potential of the mesenchymal stem cells (MSCs)
cultured on adipogenic, osteogenic, and chondrogenic media or ±100 μM H2O2 was assessed with oil red O, alizarin red, and toluidine blue
staining, respectively. (B) The MSCs isolated from rat bone marrow were culture expanded, and the percentage of positive cells expressing cKit,
CD34, CD45, CD73, CD90, and CD105 was determined with flow analysis. Scale bar, 200 μm.
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that the MSCs are multipotent, but H2O2 treatment
does not promote differentiation into adipogenic, osteo-
genic, or chondrogenic lineages.H2O2 or glucose oxidase treatment increases early
endothelial gene expression in MSCs
To determine whether H2O2 or glucose oxidase (GOX)-
mediated oxidative stress regulates endothelial gene
expression, bone marrow-derived MSCs were cultured
in media containing hydrogen peroxide (H2O2; 0 to 100
μM) for 1 week or glucose oxidase (GOX; 0 to 5 mU/ml)
for 48 hours. The mRNA expression of VEGF receptor
Flt1, vWF, and PECAM1 after exposure to H2O2 or GOX
was quantified with qRT-PCR. Although no effect was
due to lower levels of H2O2 (0.1 to 10 μM), high levels
(100 μM) significantly increased the expression of Flt1
by twofold (P < 0.05; Figure 2A), vWF by almost 2-fold
(P < 0.05; Figure 2B), and PECAM1 by 3-fold (P < 0.01;
Figure 2C). In MSCs treated with GOX for 48 hours, no
change in gene expression was seen at the lower doses
(0.01 to 2.5 mU/ml). However, at 5 mU/ml, a significant
increase in expression of Flt1 by 400-fold (P < 0.05;
Figure 2D), vWF by 150-fold (P < 0.05; Figure 2E), and
PECAM1 by 20-fold (P < 0.01; Figure 2F) was observed.A B
D E
Figure 2 Oxidative stress promotes endothelial gene expression in m
for 1 week (0 to 100 μM; A through C) or GOX for 48 hours (0 to 5 mU/ml
(B, E), and PECAM1 (C, F) was determined with qRT-PCR. Values are express
(A through C) or 18S (D through F) expression. For A through C, n ≥ 4, an
control (0 μM H2O2 or 0 mU/ml GOX) by one-way ANOVA followed by DunH2O2 or glucose oxidase treatment increases early cardiac
gene expression in MSCs
To determine whether H2O2 or GOX-mediated oxidative
stress regulates cardiac gene expression, we measured
levels of early cardiac markers nkx2-5 and α-myosin
heavy chain (αMHC). Whereas treatment of MSCs with
low levels of H2O2 (0.1 to 10 μM) had no effect on
αMHC levels, treatment with 100 μM H2O2 significantly
increased expression by 2-fold (P < 0.05; Figure 3A)
compared with time-matched, untreated controls. To
confirm with another early cardiac marker, nkx2-5, gene
expression was measured. As shown in Figure 3B, the ex-
pression of nkx2-5 increased by nearly 2-fold (P < 0.05) in
100 μM H2O2-treated MSCs. In MSCs treated with GOX
for 48 hours, no change in gene expression was seen at the
lower doses (0.01 to 2.5 mU/ml). In MSCs treated with
5 mU/ml GOX, a 30-fold increase in expression of
αMHC (P < 0.001; Figure 3C) was observed, along with a
75-fold increase in nkx2-5 expression (P < 0.05; Figure 3D).H2O2 or glucose oxidase treatment negatively modulates
smooth muscle and fibroblast gene expression in MSCs
To identify whether H2O2 regulated expression of smooth
muscle markers, the levels of the early smooth muscle
markers, smooth muscle α-actin (sm α-actin) and theC
F
esenchymal stem cells (MSCs). MSCs were treated with either H2O2
; D through F). Expression of the endothelial markers Flt1 (A, D), vWF
ed as mean ± SEM after normalizing gene expression to GAPDH
d D through F, n ≥ 6. *P < 0.05 and **P < 0.01 when compared with
nett posttest.
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Figure 3 Oxidative stress regulates cardiac gene expression in mesenchymal stem cells (MSCs). MSCs were treated with either H2O2 for 1
week (0 to 100 μM; A, B) or GOX for 48 hours (0 to 5 mU/ml; C, D). Expression of the cardiac markers αMHC (A, C) and nkx2-5 (B, D) was
determined with qRT-PCR. Values are expressed as mean ± SEM after normalizing gene expression to GAPDH (A, B) or 18S (C, D) expression. For
A and B, n ≥ 4; C and D, n ≥ 5. *P < 0.05 and ***P < 0.001 when compared with control (0 μM H2O2 or 0 mU/ml GOX) with one-way ANOVA
followed by Dunnett posttest.
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with 100 μM H2O2 significantly decreased expression of
sm α-actin by 3-fold (P < 0.01; Figure 4A) and sm22α ex-
pression by 2-fold (P < 0.01; Figure 4B). Similarly, the ex-
pression of vimentin, an intermediate-filament protein
characteristic of fibroblasts, was significantly decreased by
1.5-fold in both 1 μM (P < 0.05) and 100 μM H2O2-treated
MSCs (P < 0.01), as shown in Figure 4C. No change in ex-
pression of sm α-actin, sm22α, and vimentin was observed
in MSCs treated with GOX (0 to 5 mU/ml), as in Figure 4D
through F.H2O2 or glucose oxidase treatment induces Notch1
signaling
As the Notch signaling pathway has been shown to be
critical for cardiovascular development and differentiation,
we analyzed the expression levels of the cell-surface recep-
tor Notch1 and its ligand Jagged1 (Jag1) in H2O2- and
GOX-treated MSCs. High levels of H2O2 (100 μM) aug-
mented Notch1 gene expression by 1.5-fold after 1 week
and significantly increased Notch intracellular domain
(NICD) cleavage (P < 0.05 for gene, P < 0.01 for NICD
cleavage, Figure 5A and B), while decreasing Jagged1
(Jag1) expression by about 1.5-fold (P < 0.05, Figure 5F).
Moreover, the expression of the downstream targets ofNotch1, Hes5, was increased by up to twofold in MSCs
treated with 100 μM H2O2 (P < 0.05, Figure 5D) and Hey1
by 1.5-fold (P < 0.01; Figure 5E). Although no change in
gene expression was observed in MSCs treated with 0 to
2.5 mU/ml GOX, a significant increase in expression of
Notch1 (15-fold; P < 0.05; Figure 5C), Hes5 (150-fold;
P < 0.05; Figure 5G), Hey1 (150-fold; P < 0.01; Figure 5H),
and a significant decrease in expression of Jag1 (P < 0.05;
Figure 5I) was observed in MSCs treated with 5 mU/ml
GOX.mRNA analysis of Notch1-related genes regulated by GOX
To determine the Notch1-related genes that were regu-
lated in MSCs treated with 5 mU/ml of GOX, a PCR
array was performed. The data were analyzed and
grouped based on known associated function of the
gene. As shown in Figure 6A, treatment of MSCs with 5
mU/ml of GOX resulted in an increase in expression of
(a) Wnt11 (fivefold) and its receptor Fzd3 (3-fold), (b)
genes involved in cell adhesion and proliferation (Cd44,
Ccnd1, Cflar; about 3-fold), (c) ligands for Notch1 (Dll1,
Dll4; 3-5 fold), (d) components of γ-secretase complex
involved in Notch1 processing (Psen1, Mfng, Lfng,
hr, Neurl; 3 to 15-fold); and (e) downstream target
of Notch1 (Hes5; fivefold). As Wnt11 is a known
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Figure 4 Oxidative stress differentially modulates smooth muscle and fibroblast gene expression in mesenchymal stem cells (MSCs).
MSCs were treated with either H2O2 for 1 week (0 to 100 μM; A through C) or GOX for 48 hours (0 to 5 mU/ml; D through F). Expression of the
smooth muscle markers sm α-actin (A,D), sm22α (B,E), and the fibroblast marker vimentin (C, F) was determined with qRT-PCR. Values are expressed as
mean ± SEM after normalizing gene expression to GAPDH expression. For A through C, n ≥ 3; and D-F, n = 6. *P < 0.05 and **P < 0.01 when
compared with control (0 μM H2O2 or 0 mU/ml GOX) by one-way ANOVA followed by the Dunnett posttest.
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was validated in MSCs treated with GOX (0 or 5 mU/
ml). As shown in Figure 6B, a significant increase in
Wnt11 expression was observed in MSCs treated with 5
mU/ml GOX. The results were also validated by using car-
diac progenitor cells, in which a similar significant in-
crease was observed (Figure 6B, bottom).
H2O2 and glucose oxidase regulate cardiogenic gene
expression in MSCs through Notch1
To determine the link between increased Notch1 gene
expression and activity by H2O2 treatment and cardiogenic
gene regulation, MSCs were treated with a γ-secretase
inhibitor IX DAPT (10 μM) for 1 week with or without
100 μM H2O2. γ-Secretase is required for the release of the
active Notch1 intracellular domain (NICD) [22], and thus
its inhibition blocks Notch1 activation. To demonstrate
that DAPT inhibits Notch1 activation, MSCs were treated
with DAPT (10 μM) for 1 week with or without 100 μM
H2O2, and protein levels of NICD were measured with
Western blotting. As shown in Additional file 1, Figure S1,
DAPT decreases NICD expression in the presence of
100 μM H2O2. Inhibition of Notch1 signaling by DAPT
for 1 week showed a small but nonsignificant decreaseon basal αMHC expression, but prevented the increase
seen in 100 μM H2O2-treated cells (P < 0.05 versus
H2O2 alone; Figure 7A). A similar effect of DAPT was
observed in the expression pattern of the endothelial
marker Flt1, in which Notch1 inhibition prevented the
increase in Flt1 expression by 100 μM H2O2 (P < 0.05
versus H2O2 alone; Figure 7B). Interestingly, inhibition
of basal Notch1 signaling by DAPT decreased expres-
sion of sm α-actin by 4-fold (P < 0.001, Figure 7C) and
sm22α by 3-fold (P < 0.001, Figure 7D). This decrease was
further augmented by the combined treatment with 100
μM H2O2 and DAPT with a 10-fold and 6-fold decrease in
expression of sm α-actin and sm22α, respectively (P < 0.001
versus H2O2 alone, Figure 7C and D).
To determine whether GOX mediated changes in car-
diogenic gene expression through Notch1 signaling,
MSCs were treated with 5 mU/ml GOX in the presence
of a negative control siRNA (siNC) or siNotch1 for 48
hours. MSCs were transfected with siRNA by using
oligofectamine, as it resulted in the highest transfection
efficiency when compared with other commercially
available reagents (Additional file 1, Figure S2A). As
shown in Additional file 1, Figure S2B, siNotch1 signifi-
cantly decreased mRNA expression of Notch1 (P < 0.05)
A B C
D E F
G H I
Figure 5 Oxidative stress increases expression of Notch1 and its downstream targets. Mesenchymal stem cells (MSCs) were treated with
either H2O2 for 1 week (0 to 100 μM; A, B, D, E, F) or GOX for 48 hours (0 to 5 mU/ml; C,G through I). The mRNA expression levels of Notch1
(A, C), Hes5 (D, G), Hey1 (E, H), and the ligand Jagged1 (F, I) was determined with qRT-PCR. (B) Quantification of expression of activated Notch1
(NICD) with representative Western blot image. Values are expressed as mean ± SEM after normalizing gene expression and Western blots to
GAPDH (A,B,D,E,F) or 18S (C,G, H,I) expression and protein, respectively. For A, B, and D through F, n ≥ 4; C and G through I, n ≥ 6; *P < 0.05
and **P < 0.01 when compared with control (0 μM H2O2 or 0 mU/ml GOX) by one-way ANOVA followed by the Dunnett posttest and Student
unpaired t test for B.
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Further, siNotch1 decreased the GOX-induced increase
in Notch1 expression comparable to untreated cells,
whereas the siNC had no effect (Additional file 1, Figure
S3A and B). As shown in Figure 7E and F, addition of
siNotch1 showed a trend toward decreasing GOX-
induced increase in expression of cardiac αMHC and
Flt1 with no significant effect of siNC. The expression of
the smooth muscle markers (sm α-actin and sm22α) was
unaltered by addition of GOX in presence or absence of
siNC or siNotch1 (Figure 7G, H).H2O2 and glucose oxidase regulate cardiogenic protein
expression
To verify whether the changes in cardiogenic gene
expression translated to changes in protein expression,
levels of the cardiac marker αMHC, endothelial marker
Flt1, and smooth muscle α-actin were determined with
flow analysis (Figure 8A). As shown in the grouped data
in Figure 8B, GOX induced a 4-fold increase in cardiac
αMHC-expressing cells (left; P < 0.05), a 1.4-fold increase
in Flt1-expressing cells (middle; P = 0.07), and a 1.5-fold
decrease in sm α-actin-expressing cells (right; P < 0.05).
A B
Figure 6 Polymerase chain reaction (PCR) array analysis of Notch1-related genes. Gene expression of Notch1-related genes in MSCs treated
with GOX (0 or 5 mU/ml) was analyzed by using a PCR array. (A) Fold increase in gene expression in 5 mU/ml GOX-treated MSCs over control
cells was normalized to β-actin. (B) Validation of increase in Wnt11 expression on 5 mU/ml GOX treatment in MSCs (top, P < 0.05) and CPCs
(bottom, P = 0.08).
0
10
20
30
40
α
M
H
C
/1
8S
GOX       - +            +             +
siNotch1       - -             +          -
si NC       - -          +
0
100
200
300
400
**
F
lt
1/
18
S
          -              +              +             +
siNotch1     - -              +           -
si NC     - -               -           +
0.0
0.5
1.0
1.5
2.0
2.5
      GOX          -              +              +             +
      siNotch1    - -              +           -
      si NC     - -               -           +
sm
 α
−
a
ct
in
/1
8S
0.0
0.5
1.0
1.5
sm
22
α
/1
8S
      GOX          -              +              +             +
      siNotch1    - -              +           -
      si NC     - -               -           +
*
GOX
A B C
E F G
D
H
Figure 7 H2O2 and glucose oxidase (GOX) regulate cardiogenic gene expression in mesenchymal stem cells (MSCs) in both Notch1-
dependent and -independent manners. MSCs were treated with 100 μM H2O2 ± Notch1 inhibitor DAPT (A through D) or with 5 mU/ml GOX ±
siNotch1 (E through H). Expression of the cardiac marker αMHC (A, E), endothelial marker Flt1 (B,F), and the smooth muscle markers sm α-actin (C, G)
and sm22α (D, H) were determined with qRT-PCR. Values are expressed as mean ± SEM after normalizing gene expression to GAPDH (A-D) or 18S
(E-H) expression. n ≥ 4, *P < 0.05 and **P < 0.01 compared with control (0 μM H2O2), or #P < 0.05 compared with 100 μM H2O2 by one-way ANOVA
followed by Bonferroni posttest.
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Figure 8 Quantification of glucose oxidase (GOX)-mediated cardiogenic protein expression in mesenchymal stem cells (MSCs). MSCs
were treated with GOX (5 mU/ml) for 48 hours. Expression of the cardiac proteins (αMHC, Flt1, and sm α-actin) was determined with flow
cytometry (A) and quantified in B. Values are expressed as mean ± SEM with n ≥ 3. *P < 0.05 versus control with the Student paired t test.
Figure 9 Oxidative stress regulates cardiogenic gene expression in cardiac progenitor cells. Cardiogenic gene expression in cardiac
progenitor cells treated with GOX (0 or 5 mU/ml) was determined with qRT-PCR. An increase in expression of Notch1 (P < 0.001), Hes5 (P < 0.05),
flt1 (P = 0.08), vWF (P < 0.05), nkx2-5 (P < 0.01), and sm22α (P < 0.05) was observed. Values are expressed as mean ± SEM after normalizing gene
expression to 18S expression: n = 3, *P < 0.05, **P < 0.01, ***P < 0.001 compared with control (0 mU/ml GOX) with the Student unpaired t test.
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cardiac progenitor cells
To determine whether the effects of oxidative stress me-
diated by H2O2 are specific for MSCs, we subjected
adult cardiac progenitor cells to GOX treatment. Inter-
estingly, an increase in expression of Notch1 by 15-fold
(P < 0.001) and Hes5 by 175-fold (P < 0.05), along with
changes in cardiogenic gene expression similar to the
response of MSCs, was observed (Figure 9).
Discussion
Previous studies showed that transplantation of MSCs in
the heart after MI leads to small but significant func-
tional improvements [5]. Understanding the molecular
mechanisms by which MSCs promote cardiac function,
especially in the oxidative microenvironment after MI,
will greatly aid in improving efficacy of stem cell-based
therapies. After myocardial infarction, elevated levels of
ROS have been found at the infarct site [10], suggesting
that ROS such as H2O2 might influence the differenti-
ation and function of implanted MSCs. As substantial
amounts of ROS have been found in the area at risk
after MI [23], and as ROS have been identified to play a
critical role in the differentiation of other stem cell types
[24,25], we chose to study the effect of H2O2 on MSC
differentiation in vitro.
Here we showed that MSCs that were subjected to
pulses of pathophysiologic levels of H2O2 for 1 week or
continuous H2O2 produced by oxidation of glucose in
the extracellular media by GOX for 48 hours increased
the expression of early cardiac and endothelial genes
with decreased expression of early smooth muscle genes.
Although only a twofold increase in cardiac markers is
observed with H2O2 treatment, addition of GOX results
in a more robust increase of 30-fold for αMHC and 75-
fold for nkx2-5, which are comparable to neonatal rat
ventricular cardiomyocytes, with 40-fold and 100-fold
higher expression of αMHC and nkx2-5, respectively,
when compared with untreated MSCs. These results
were in agreement with those reported for human
embryonic stem cells (ESCs) [25]. Similar results were
obtained when adult heart-resident cardiac progenitor
cells (CPCs) were treated with GOX. These data demon-
strate redox-sensitive alteration in cardiogenic gene
expression in MSCs and CPCs.
Our results also demonstrate that only high levels of
exogenous H2O2 (100 μM) and high concentrations
of GOX (5 mU/ml) were able to regulate expression of
Notch1 and cardiogenic genes. We believe this very
narrow threshold effect may be due to a combination of
factors, such as presence of basal H2O2 and constitutive
expression of antioxidant enzymes by cells. Unpublished
data from our laboratory demonstrate basal H2O2 levels
of 1 μM in cultured stem cells, as measured withelectron paramagnetic spin resonance. Recent reports
demonstrate that many stem cells, including MSCs, con-
tain higher levels of antioxidants [26,27]. We measured
H2O2 levels in stem cells after addition of 100 μM H2O2
and found that the concentration reduced to 12 μM,
within an hour, indicating rapid scavenging of exogenous
oxidants.
Finally, recent data from human MSCs determined
higher levels of catalase and glutathione peroxidase, with
no changes in superoxide dismutase compared with
other stem cells and fully differentiated cells [27]. In that
study, a threshold response with human MSCs demon-
strated almost 80% survival at 4 mM H2O2, decreasing
to <10% at 8 mM. Our studies indicate robust survival
at 100 μM H2O2 and 5 mU/ml GOX with cellular
responses, but showed higher concentrations to be po-
tentially cytotoxic. Taken together, these data demon-
strate that many cells, especially stem and progenitor,
have threshold responses with small windows of dose-
responses.
Next, we investigated whether H2O2 regulates any sig-
naling pathway involved in stem cell differentiation. One
of the signaling pathways that greatly influence stem cell
differentiation is the Notch signaling pathway [28].
Therefore, we investigated whether interplay existed
between H2O2 and Notch1 signaling pathways. Interest-
ingly, the mRNA level of Notch1 as well as proteolytic
cleavage of the Notch1 intracellular domain (NICD) was
upregulated by treatment with 100 μM either H2O2 or
GOX, suggesting that high levels of H2O2 affect expres-
sion of both the mRNA and protein activity of Notch1.
Although only a 1.5-fold increase in mRNA and twofold
increase in NICD protein is observed, reports suggest
that very small changes in Notch1 activation are suffi-
cient to induce Notch1 signaling [11]. Furthermore, this
increase in Notch1 also significantly increased mRNA
expression of downstream targets of Notch1. As MSCs
were pulsed with H2O2 for 1 week, discontinuous oxida-
tive stress resulted in small fold changes in cardiac gene
expression. Although these changes may not represent
true differentiation, they suggest that H2O2 levels influ-
ence cardiac gene expression in MSCs.
Although upregulation of cardiac and endothelial
genes by Notch1 signaling may appear to be counterin-
tuitive, given the role of Notch signaling in suppressing
cardiomyogenesis in ESCs [19], upregulation of nkx2-5
and vWF is consistent with reports indicating involve-
ment of Notch1 signaling in regulating these genes in
cardiac progenitor cells and bone marrow stromal cells,
respectively [18,29]. Our observation that treatment with
100 μM H2O2 or 5 mU/ml GOX decreased expression
of the Notch1 ligand Jagged1 in MSCs is consistent with
previous reports of an inverse relation between expression
levels of Notch1 and Jagged 1 in other cell types [30].
Figure 10 Proposed model of H2O2/GOX-mediated induction of cardiogenic gene expression in MSCs.
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sion at the mRNA level, we sought to determine
whether these changes translated correspondingly
at the protein level. Flow analysis of GOX-treated
MSCs indicated that a small number of MSCs have
high expression of αMHC, along with increased Flt1
expression and decreased sm α-actin expression. These
results suggest that GOX treatment increases the fre-
quency αMHC- and Flt1-positive cells while decreasing
sm α-actin-positive cells.
The mechanism of upregulation of Notch1 activation
by H2O2 may be due to activation of enzymes involved
in Notch1 cleavage and processing. It is possible that
H2O2 may increase Notch1 activation via γ-secretase
activation, as H2O2-mediated increase in γ-secretase
activation has been demonstrated in the pathogenesis of
Alzheimer disease [31]. Pharmacologic inhibition of γ-
secretase activity by using DAPT inhibits Notch1 activa-
tion in different stem cells [29,32]. Therefore, to determine
whether H2O2 regulates cardiogenic gene expression in
MSCs through Notch1 signaling, we blocked Notch1 acti-
vation daily by using DAPT and analyzed expression of the
different cardiogenic markers in the presence and absence
of 100 μM H2O2. Among the markers analyzed, the in-
crease in expression of the high-affinity VEGF receptor
Flt1 and the cardiac marker αMHC observed with 100 μM
H2O2 was abrogated by co-treatment with DAPT, indicat-
ing that H2O2 regulates Flt1 and αMHC expression
through Notch1 signaling. We attempted knockdown of
Notch1 by using siRNA; however, this was not successful,
as siRNAs that significantly reduced Notch1 gene expres-
sion greatly reduced cell survival over the 1-week period of
treatment.
To determine whether glucose oxidase (GOX) medi-
ated acute changes in cardiogenic gene expression
through Notch1 signaling, MSCs were transfected with
siNotch1 along with GOX for 48 hours. Treatment with
siNotch1 showed a strong trend toward decreasing the
GOX-mediated increase in αMHC and Flt1, whereas noeffect was observed on smooth muscle gene expression
by addition of GOX ± siNotch1. As ADAM17 is involved
in Notch1 processing, MSCs were pretreated with an
ADAM17 inhibitor. No effect was observed on H2O2-
induced gene expression, nor was the expression or ac-
tivity of ADAM17 altered by H2O2 treatment, suggesting
the importance of the γ-secretase component of this
pathway (Additional file 1, Figure S4). Further, treatment
with GOX increased expression of enzymes involved in
processing of Notch1 and Jagged1, such as Mfng, Lfng,
and Neurl, indicating that H2O2 influences both notch1
cleavage and processing enzymes.
Expression of smooth muscle markers decreased sig-
nificantly on treatment with 100 μM H2O2. Inhibition of
Notch1 also decreased basal expression of smooth
muscle markers, in keeping with prior findings [33].
Interestingly, co-treatment of MSCs with H2O2 and
DAPT resulted in a further decrease in smooth muscle
markers. This indicates that H2O2 decreases smooth
muscle gene expression through a parallel pathway, and
that activation of Notch serves as a compensatory mech-
anism to stabilize smooth muscle gene expression.
Finally, expression of vimentin was also decreased by
both H2O2 and GOX treatment. Although vimentin is
expressed in many cell types, it is most prevalent in fi-
broblasts and is thought to be a partial marker of fibro-
blastic lineage [34]; lower expression could lead to
decreased fibrosis.
To understand the mechanism by which oxidative
stress mediated by GOX resulted in robust increases in
cardiogenic gene expression, the expression of Notch1-
related genes in GOX-treated MSCs was analyzed with a
PCR array. Interestingly, Wnt11 expression was in-
creased in GOX-treated MSCs. Wnt11 signaling has
been shown to promote cardiomyogenic differentiation
of human endothelial progenitor cells and mouse mar-
row mononuclear cells [35,36]. Moreover, Wnt signaling
has been identified as a downstream target of Notch1
that regulates expression of cardiac transcription factors
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development [37,38]. MSCs overexpressing Wnt11 have
been shown to be cardioprotective after oxidative stress
in rats through increased cardiac gene expression and
release of paracrine factors [39,40].
Of note, MSCs used in this study were a heterogenous
mix of cells present in the adult rat bone marrow. It is un-
clear whether one particular lineage in the heterogenous
mix is most responsible for these changes or whether
Notch1 is activated in all these cell types. Although pub-
lished literature suggests that all these cells express Notch
[18,41], the optimal cell type must be determined.
Conclusion
To our knowledge, this study demonstrates for the first
time two important findings in the field of stem cell ther-
apy. Oxidative stress in rat bone marrow-derived MSCs
and heart-derived CPCs (a) regulates expression of se-
lected cardiac, endothelial, and smooth muscle genes, and
(b) promotes Notch1 signaling and downstream Wnt11
activation. Our current working model is depicted in
Figure 10 and summarizes the findings of our study. Given
that cardiogenic gene expression of two adult progenitor
types (MSCs and CPCs) was induced by high levels of
H2O2/GOX via Notch1 signaling, this may represent an
important conserved response. As both of these cell types
are in clinical trials, this study may have implications in
developing adult stem/progenitor cell-based therapies.
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